XANITROL Trademark

Trademark Overview

On Monday, May 30, 2011, a trademark application was filed for XANITROL with the United States Patent and Trademark Office. The USPTO has given the XANITROL trademark a serial number of 85333297. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 13, 2019. This trademark is owned by InQpharm Europe Limited. The XANITROL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, combination of ingredients sold as a component of fat burner; combination of ingredients sold as component of dietetic, nutraceutical and pharmaceutical preparations in tablet, capsule, powder or liquid form for the treatment of metabolic syndrome related diseases, general weight management and the treatment of obesity; combination of ingredients derived from plant extracts in liquid, powder, gel or oil form for dietetic, nutraceutical or pharmaceutical use for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity
xanitrol

General Information

Serial Number85333297
Word MarkXANITROL
Filing DateMonday, May 30, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 13, 2019
Registration Number4289683
Registration DateTuesday, February 12, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2011

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations, namely, combination of ingredients sold as a component of fat burner; combination of ingredients sold as component of dietetic, nutraceutical and pharmaceutical preparations in tablet, capsule, powder or liquid form for the treatment of metabolic syndrome related diseases, general weight management and the treatment of obesity; combination of ingredients derived from plant extracts in liquid, powder, gel or oil form for dietetic, nutraceutical or pharmaceutical use for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateFriday, April 9, 2010
First Use In Commerce DateFriday, February 17, 2012

Trademark Owner History

Party NameInQpharm Europe Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHITCHIN, HERTFORDSHIRE SG40TY
GB
Party NameInQpharm Europe Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHITCHIN, HERTFORDSHIRE SG40TY
GB
Party NameInQpharm Europe Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHitchin
GB

Trademark Events

Event DateEvent Description
Friday, September 13, 2019CANCELLED SEC. 8 (6-YR)
Monday, February 12, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 12, 2013REGISTERED-PRINCIPAL REGISTER
Friday, January 11, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 10, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, January 7, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 7, 2013EXAMINER'S AMENDMENT ENTERED
Monday, January 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 7, 2013EXAMINERS AMENDMENT E-MAILED
Monday, January 7, 2013SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, July 11, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 11, 2012NON-FINAL ACTION E-MAILED
Wednesday, July 11, 2012SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 13, 2012STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 15, 2012USE AMENDMENT FILED
Friday, June 8, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 15, 2012TEAS STATEMENT OF USE RECEIVED
Friday, May 4, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 4, 2012TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 21, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 17, 2011ASSIGNED TO LIE
Wednesday, October 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 25, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, October 25, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 25, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, October 25, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 18, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, October 18, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 18, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, October 18, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, October 14, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 14, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 14, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 19, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 19, 2011NON-FINAL ACTION E-MAILED
Monday, September 19, 2011NON-FINAL ACTION WRITTEN
Thursday, September 15, 2011ASSIGNED TO EXAMINER
Friday, June 3, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 2, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

xanitrol treatment combination pharmaceutical ingredients syndrome metabolic form related general obesity